arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Tarsus Pharmaceuticals, Inc.

TARS Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$59.28
▼ -1.8% Today
as of Jun 7, 07:29 ET
Last 30 days -4.53% Apr 28 → Jun 05
$56.79 $59.04 $61.30 $63.55 $65.80 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$60.86
High
$62.50
Low
$58.80
Volume
$358,815
Avg Vol
$617,315
Mkt Cap
$2.6B
P/E (TTM)
Beta
52w High
$85.25
52w Low
$38.51
Div Yield
Shares Out
$43M

Overview

52-week range
$39
$85
44% of range
Avg surprise (last 2)
+36.2%
Avg reaction (last 2)
-1.8%
0% positive
Latest IV / EM
65%
EM ±9.1% · $60 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.28$-1.00$-0.72$-0.44$-0.16 Actual $-1.17Actual $-1.28Actual $-1.01Actual $-0.88Actual $-0.61Actual $-0.64Est $-0.69Actual $-0.48Actual $-0.30Actual $-0.16Est $-0.46 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-33M$18M$68M$119M$170M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.16 $-0.46 +65.2% +75.0% -0.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.30 financials
Mon Jun 30, 2025Jun 2025 $-0.48 financials
Thu May 1, 2025Mar/2025 $-0.64 $-0.69 +7.2% -3.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.61 financials
Sun Jun 30, 2024Jun 2024 $-0.88 financials
Sun Mar 31, 2024Mar 2024 $-1.01 financials
Sat Sep 30, 2023Sep 2023 $-1.28 financials
Fri Jun 30, 2023Jun 2023 $-1.17 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$162M$119M$103M$78M$48M$41M
Cost of revenue$9M$5M
Gross profit
Operating income$-6M$-15M$-22M$-26M$-25M$-33M
Net income$-7M$-13M$-20M$-25M$-23M$-33M
EPS (diluted)$-0.16$-0.30$-0.48$-0.64$-0.61$-0.88

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$102M$184M$113M$97M$176M$95M$176M$181M
Inventory$5M$4M$4M$4M$3M$3M$3M$2M
Total current assets$537M$523M$502M$474M$481M$357M$357M$363M
Total assets$581M$562M$535M$495M$501M$377M$376M$377M
Long-term debt$73M$72M$72M$72M$72M$72M$72M$72M
Total liabilities$232M$219M$199M$162M$158M$152M$139M$125M
Total equity$349M$343M$335M$333M$342M$225M$237M$252M

Implied volatility — last 90 days

60%62%65%67%70% Jun 07 — IV 65% · EM ±9.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.